Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:314

https://doi.org/10.1186/s12879-017-2408-7

Received: 4 January 2017

Accepted: 18 April 2017

Published: 28 April 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
4 Jan 2017 Submitted Original manuscript
21 Feb 2017 Reviewed Reviewer Report - Robert Moss
23 Feb 2017 Reviewed Reviewer Report - Wendong Liu
24 Mar 2017 Author responded Author comments - Teresa Kauf
Resubmission - Version 2
24 Mar 2017 Submitted Manuscript version 2
13 Apr 2017 Author responded Author comments - Teresa Kauf
Resubmission - Version 3
13 Apr 2017 Submitted Manuscript version 3
Publishing
18 Apr 2017 Editorially accepted
28 Apr 2017 Article published 10.1186/s12879-017-2408-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Shire International GmbH
(2)
Merck & Co., Inc.
(3)
MAPI Group
(4)
Shire
(5)
University of Washington
(6)
Merck & Co., Inc.

Advertisement